Rise in testosterone level boosts young women's running capacity
A rise in the level of the male hormone testosterone significantly boosts young physically active women's capacity to run for longer, reveals a new study.
Read moreProstate Health
Large, long-term study suggests link between eating mushrooms and a lower risk of prostate cancer
Results from the first long-term cohort study of more than 36,000 Japanese men over decades suggest an association between eating mushrooms and a lower risk of prostate cancer.
Read moreBiomarker in urine may offer noninvasive detection of prostate cancer
A research study has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection.
Read moreFirst prostate cancer therapy to target genes delays cancer progression
For the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial. This marks a significant advance for prostate cancer treatment, which has lagged behind other common cancers with regard to precision therapy, now the standard of care in breast, ovarian and lung cancers.
Read moreTrial finds high-dose radiation effective for men whose prostate cancer has spread
A randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer.
Read moreFathering children by assisted reproduction linked to increased risk of prostate cancer
Men who became fathers through assisted reproduction techniques seem to be at higher risk for prostate cancer and early onset prostate cancer compared with men achieving fatherhood naturally.
Read morePromising prostate cancer drug candidates identified
Cancer researchers have identified some promising drug candidates by using high-throughput screening methods to test tens of thousands of molecules.
Read morePotential therapeutic target for prostate cancers with PTEN mutation
PTEN, a tumor suppressor gene mutated in about 20% of prostate cancers, relies on another gene, ARID4B, to function.
Read more